Main > > >ARTERY. *

---

Cardio.>Coronary Artery Disease. DIAG.:
Catheterization. Vascular Closure Sys-
tem.
(*) Company; Patent Assignee; Trade-
Mark & Web-Site Available on Request
UpDate: 2019. 03.14.




Cardio.>Coronary Artery Disease. DIAG.:
Fractional Flow Reserve (FFR)+coronary
Computer Tomography Angiography (cCTA)
Imaging.
CA Approval Date : ?
EU Approval Year : 2011.
JP Approval Date : 2016. 11.17.
USA Approval Date: 2014. 12.01.
(*) Company; Patents; Product Name &
Web-Site Available on Request.
UpDate: 2019. 09.23.




Cardio.>Coronary Artery Disease. DIAG.:
GuideWire Fractional Flow Reserve (FFR)
During Percutaneous Coronary Interven-
tion (PCI).
Indications:
to direct a catheter through a blood vessel and to measure blood pressure
in the heart and in the coronary blood vessels.
Patient Outcomes Improvement>
>over Angiography alone.
EU Launch Date: 2016. 05.18.
(*) Company; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2019. 03.12.




Cardio.>Coronary Artery Disease. Lipid Core Plaque (LCP). Detection & Analysis. IntraVascular UltraSound (IVUS)+Near InfraRed Spectroscopy (NIRS). Heart Attack (Myocardial Infarction) Prognos- tics.
JP Approval Date : 2017. 08.
JP Launch Date : 2018. 07.31.
USA Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.11.




Cardio.>Coronary Artery Disease. Multi Vessel CAD. NonInvasive Evaluation. Fractional Flow Reserve (FFR) Device.
3D Reconstruction of Entire Coronary Tree with FFR values along each Vessel.
Delivers Objective FFR Guidance needed
to optimize PCI therapy decisions.
Derived from Routine X-Rays ACQuired during a diagnostic Angiogram procedure.
Performed Intra-Procedurally during Coronary Angiography.
Use during PCI Intervention.
USA Approval Date: 2018. 12.20.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 07.08.




Cardio.>Coronary Artery Disease. TREAT.: BioResorbable Scaffold (“BRS”).
EU Launch Date: 2018. 10.31.
(*) Company; Patent; TradeMarks & Web-
Sites Available on Request.
UpDate: 2019. 03.31.




Cardio.>Coronary Artery Disease. TREAT.: Co-Cr Stent.>Bifurcation (Site where One Artery Branches from Another).
EU Approval Date : 2011. 05.18.
USA Approval Date: 2017. 03.06.
(*) Companies; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2019. 03.31.




Cardio.>Coronary Artery Disease. TREAT.:
PolyPhosphazene NanoCoated Non-Drug Elu-
ting Co-Cr Stent.
Minimum 1-month (Dual AntiPlatelet Ther- apy (DAPT) Requirement.
EU Approval Year : 2012.
EU Launch Year : 2013.
USA Approval Date: 2017. 03.01.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.15.




Cardio.>Coronary Artery Disease. TREAT.:
Sirolimus Eluting Stent.
EU Approval Year : 2011.
USA Approval Date: 2019. 02.22.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 09.14.


>ARTERY. *'s products
This section has no products